Human Reproduction, Vol. 17, No. 4, 1106-1111,
April 2002
© 2002 European Society of Human Reproduction and Embryology
Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?
IVF Unit, Hammersmith Hospital, Imperial College, London, UK
BACKGROUND: It has been previously reported that a group of 12 infertile women, who had a normal baseline hormonal profile and did not respond to repeated ovarian stimulation with gonadotrophins, developed ovarian failure within a few months. Based on this observation, we carried out a controlled retrospective cohort study to examine whether non-response to ovarian stimulation is linked to early ovarian failure. METHODS: All patients aged 35–40 years who had cancelled IVF cycles for non-response between 1991 and 1993 in our centre were asked to report on the subsequent development of menopausal symptoms, menopause or commencement of hormone replacement therapy. A control group consisted of patients with the same age and similar medical history, who had IVF the same year and responded well. RESULTS: Eleven out of the 12 patients of the non-response group developed menopausal symptoms within 7 years, compared with only four out of 24 in the control group. Similarly, eight out of 12 non-responders either went into menopause or started using hormone replacement therapy compared with one out of 24 in the control group. Using Fisher's exact test, the differences were highly significant (P < 0.0001). The median age at development of menopausal symptoms in the study group was 40 years (range 38–45). The median time between non-response and development of menopausal symptoms was 4 years (range 1–7). CONCLUSION: We carried out a controlled retrospective cohort study that showed a strong association between an extremely poor response to ovarian hyperstimulation and early ovarian failure.
Key words: IVF/menopause/ovarian failure/ovarian reserve/poor response
1 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, Foresterhill, Aberdeen AB25 2ZD, UK. E-mail: dnikolaou{at}talk21.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-Mullerian hormone measurement in a routine IVF program Hum. Reprod., June 1, 2008; 23(6): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.H. Woldringh, M.H.A. Frunt, J.A.M. Kremer, and M.E.A. Spaanderman Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies Hum. Reprod., November 1, 2006; 21(11): 2948 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gleicher and D. Barad Unexplained infertility: Does it really exist? Hum. Reprod., August 1, 2006; 21(8): 1951 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nikolaou and C. Gilling-Smith Early ovarian ageing: are women with polycystic ovaries protected? Hum. Reprod., October 1, 2004; 19(10): 2175 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sadrzadeh, W.A.J. Klip, F.J.M. Broekmans, R. Schats, W.N.P. Willemsen, C.W. Burger, F.E. van Leeuwen, C.B. Lambalk, and for the OMEGA Project group Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort Hum. Reprod., October 1, 2003; 18(10): 2225 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nikolaou and A. Templeton Early ovarian ageing: a hypothesis: Detection and clinical relevance Hum. Reprod., June 1, 2003; 18(6): 1137 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Hohmann, N. S. Macklon, and B. C. J. M. Fauser A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment for in Vitro Fertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist Protocol J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.A.J. van Rooij, F.J.M. Broekmans, E.R. te Velde, B.C.J.M. Fauser, L.F.J.M.M. Bancsi, F.H.d. Jong, and A.P.N. Themmen Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum. Reprod., December 1, 2002; 17(12): 3065 - 3071. [Abstract] [Full Text] [PDF]
|
|